Vibegron not checked

Urovant Sciences GmbH · RVT-901 · MK-4618

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 2/3 trial completes
Trials
1 active
6 in total · 1 in the EU

What this is

How it works
beta3-Adrenergic Agonist FDA class
How it’s given
“Participants will be administered Vibegron orally, once daily (QD)”In the company’s words, NCT05491525 on ClinicalTrials.gov
Tested for
Neurogenic Detrusor Overactivity
Main trialPhase 2/3
“The purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC”In the company’s words, NCT05491525 on ClinicalTrials.gov
Other names
RVT-901 · MK-4618 · KRP-114V · URO-901 · KRP114V · MK4618

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 2/3Recruiting Mar 2030 Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Phase 3Completed 10 Jan 2019 A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)
Phase 3Completed 13 Jun 2019 An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).
Phase 3Completed 29 Jul 2022 Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia
Phase 3Completed 15 Jun 2023 Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)
Phase 2Completed 25 Sep 2020 Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Vibegron

Following is part of Solo: you see every change to Vibegron the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in